Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Acacianpunk
    Junior Member
    • May 2014
    • 3

    Library peak-let contamination at high end of TruSeq BioAnalyzer trace

    Hi everyone,
    We are constructing ddRad-seq libraries using a homebrew variant of the TruSeq system. The library prep was pooled and run on a BioAnalyzer before Kapa quantification and running. The resulting BioAnalyzer profile is below.

    The majority of our library is centered at the selected size of 300bp with minor adapter dimer contamination in the top sample. Both samples show some variant sized products at very low concentrations ranging from 800-6000bp. Does anyone know what these could be?

    Based on reading threads my assumptions are either beads or bubbled molecules but any suggestions would be appreciated before we sequence.

    Thank you
    Matt
    Attached Files
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    They do not look like bubbles that you are reffering. They could be remaining non-target digested DNA themselves or their amplification products or both. If size-selection was done on Pippin instrument, my previous statement would not be true. Maybe the bioanalyser reagents and run (specially ladder) should be inspected more closely for further explanation in first step. The answer might be in the modified protocol that have been used to prep libraries.
    Last edited by nucacidhunter; 06-09-2014, 06:24 PM.

    Comment

    • Acacianpunk
      Junior Member
      • May 2014
      • 3

      #3
      Great point. Size selection was gel based so any DNA coming through without adapters possibly could be amplified from at the last step.

      This is becoming problematic in quantifying the amount of material to load. We might try a weighted average and see how the cluster generation goes.

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        I would first rerun the sample on Bioanlyser to see if the trace is consistent or is due to anomaly in that particular run. If the trace is repeated the next step would be to see if those off target fragments are amplifiable or not by running a PCR with diluted library. If they are not amplified, their presence can be ignored and a qPCR quantification method should result in consistent cluster numbers. If you are using Qubit for quantification, those fragments would interfere with quantification and likely source of them should be explored. In a gel run in optimum condition and extraction you should not get those large fragments after PCR (assuming size selection is before PCR on digested-ligated DNA), although smaller fragments can be expected.

        Size selection was gel based so any DNA coming through without adapters possibly could be amplified from at the last step.
        This is less likely as the fragments without adapters will lack priming site for amplification.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM
        • GATTACAT
          Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
          by GATTACAT
          Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
          07-01-2026, 11:43 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Working...